StockData
Longeveron Inc. logo

Longeveron Inc. (LGVN) stock

LGVNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$1.92−0.19 (-9.00%)

Close on Nov 18, 2026Market cap $61.21MP/E –Yield –

Longeveron profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Longeveron's profit margin for the twelve months ending Jun 30, 2026 was -1977.6%. For fiscal 2025 it was -1893.6%, against -667.8% the year before. The highest annual figure on record is -66.1% in fiscal 2020.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-1893.6%−1225.8
FY2024Dec 31, 2024-667.8%+2352.4
FY2023Dec 31, 2023-3020.2%−1478.8
FY2022Dec 31, 2022-1541.3%−236.2
FY2021Dec 31, 2021-1305.1%−1239.0
FY2020Dec 31, 2020-66.1%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 2026-2116.0%−524.9
Q1 FY2026Mar 31, 2026-1189.9%+125.3
Q4 FY2025Dec 31, 2025-1491.5%−814.7
Q3 FY2025Sep 30, 2025-5270.8%−4699.1
Q2 FY2025Jun 30, 2025-1591.1%−861.9
Q1 FY2025Mar 31, 2025-1315.2%−574.7
Q4 FY2024Dec 31, 2024-676.8%+8891.5
Q3 FY2024Sep 30, 2024-571.7%+2832.3
Q2 FY2024Jun 30, 2024-729.3%+1866.1
Q1 FY2024Mar 31, 2024-740.5%+925.1
Q4 FY2023Dec 31, 2023-9568.3%−8361.4
Q3 FY2023Sep 30, 2023-3404.0%−2455.4
Q2 FY2023Jun 30, 2023-2595.4%−648.5
Q1 FY2023Mar 31, 2023-1665.6%+427.1
Q2 FY2022Jun 30, 2022-1206.9%−182.3
Q1 FY2022Mar 31, 2022-948.6%−121.3
Q4 FY2021Dec 31, 2021-1946.9%−1832.0
Q3 FY2021Sep 30, 2021-2092.7%−2042.4
Q2 FY2021Jun 30, 2021-1024.5%−885.7
Q1 FY2021Mar 31, 2021-827.4%−814.9
Q4 FY2020Dec 31, 2020-114.9%–
Q3 FY2020Sep 30, 2020-50.2%–
Q2 FY2020Jun 30, 2020-138.8%–
Q1 FY2020Mar 31, 2020-12.5%–

More Longeveron figures

See a number that looks wrong?